(NasdaqGM:SLGL), NESS ZIONA, Israel, May 23, 2025 (GLOBE NEWSWIRE) — Sol-Gel Technologies, Ltd. (NASDAQ: SLGL), a clinical-stage dermatology company, today announced financial results for the first quarter ended March 31, 2025. Financial Results for the First Quarter Year Ended March 31st, 2025 Total revenue in the first quarter was $1 million compared to $0.5 million […]
Sol-Gel Reports First Quarter 2025 Results GlobeNewswire May 23, 2025 NESS ZIONA, Israel, May 23, 2025 (GLOBE NEWSWIRE) — Sol-Gel Technologies, Ltd. (NASDAQ: SLGL), a clinical-stage dermatology company, today announced financial results for the first quarter ended March 31, 2025. Financial Results for the First Quarter Year Ended March 31st, 2025 Total revenue in the
CEO John Akhoian says that most skilled trades jobs cannot be outsourced and pay more than many careers that require a four-year degree Rooter Hero Plumbing & Air, a plumbing and HVAC company serving residential and commercial locations in California and Arizona, says that the high cost of a four-year university and the ability to
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO OR TO ANY PERSON LOCATED OR RESIDENT IN ANY JURISDICTION WHERE IT IS UNLAWFUL TO RELEASE, PUBLISH OR DISTRIBUTE THIS DOCUMENT Sodexo Inc. (the “Offeror”) announces the results of its previously announced tender offer (the “Offer”) to purchase for cash any and all of its outstanding
(NasdaqGM:IVVD), WALTHAM, Mass., May 23, 2025 (GLOBE NEWSWIRE) — Invivyd, Inc. (Nasdaq: IVVD), today announced that PEMGARDA(R) (pemivibart), its investigational monoclonal antibody, has been added to the National Comprehensive Cancer Network(R) (NCCN(R)) Clinical Practice Guidelines in Oncology for B-Cell Lymphomas. NCCN joins the Infectious Disease Society of America (IDSA) that updated its COVID-19 guidelines in
(NasdaqGM:VEON), Islamabad and Dubai, May 23, 2025: VEON Ltd. (Nasdaq: VEON), a global digital operator (“VEON” or “the Company”), announces that it has now secured all regulatory approvals for its strategic partnership with Engro Corporation Limited (“Engro Corp”) for the pooling and management of telecommunications infrastructure assets in Pakistan. The partnership, initially announced on December
Invivyd Announces Inclusion of PEMGARDA(R) (pemivibart) in National Comprehensive Cancer Network(R) (NCCN(R)) Clinical Practice Guidelines in Oncology for B-Cell Lymphomas GlobeNewswire May 23, 2025 WALTHAM, Mass., May 23, 2025 (GLOBE NEWSWIRE) — Invivyd, Inc. (Nasdaq: IVVD), today announced that PEMGARDA(R) (pemivibart), its investigational monoclonal antibody, has been added to the National Comprehensive Cancer Network(R) (NCCN(R))
Submission follows receipt of final federal permit. Application submitted for up to $2 billion, an increase from the $1.8billion Letter of Interest, reflecting a higher estimatednumber ofjob-years. If approved, EXIM debt financing could fund a majority of the Project's development costs to become the only domestically minedsource ofantimony. Perpetua Resources Corp. (Nasdaq: PPTA) (TSX: PPTA)
— Initial safety & efficacy in patients with Small Cell Lung Cancer (SCLC) and Non-Small Cell Lung Cancer (NSCLC) with Driver Genomic Alterations (GA) outside of Classic EGFR Mutations will be presented from clinical studies evaluating iza-bren, an EGFRxHER3 bispecific topoisomerase inhibitor- based antibody-drug conjugate (ADC) SystImmune, Inc. (SystImmune), a clinical-stage biotechnology company, today announced
VEON and Engro Corporation Advance to Closing Pioneering Infrastructure Partnership in Pakistan Following Regulatory Approvals GlobeNewswire May 23, 2025 Islamabad and Dubai, May 23, 2025: VEON Ltd. (Nasdaq: VEON), a global digital operator (“VEON” or “the Company”), announces that it has now secured all regulatory approvals for its strategic partnership with Engro Corporation Limited (“Engro